PX-6518

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePX-6518
Drug Alias Namemaesabalide IImaesabalide IVmaesabalide VImaesabalide Imaesabalide III +[8
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Diagnostics BVBA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Diagnostics BVBA
Active IndicationsN/A
Inactive IndicationsLeishmaniasis

Other Information

ATC CodeN/A
Related LinksN/A